Following is a list of current
and expired funding sources that have been listed on the OSUCCC website. To search for a particular title or words, click
on Edit / Find in your browser’s navigation bar (or Ctrl / F).
|
Title/link to website |
Summary |
Deadline |
|
NCI is
inviting applications for funding under the Small Grants Program for Cancer
Epidemiology. This program focuses on etiologic cancer research and provides
support for pilot projects, testing of new techniques, or development of
innovative projects that could provide a basis for more extended research.
Approximately 30-40 small research project grants are anticipated. Applicants
may request a project period of up to two years and a budget for direct costs
of up to $100,000 per year. Eligible are for-profit and nonprofit
organizations; public or private institutions such as universities, colleges,
hospitals and laboratories; units of state and local governments; eligible
agencies of the federal government; domestic or foreign institutions; and
faith- or community-based organizations. |
|
|
|
A
one-year grant for junior faculty at the level of Assistant Professor, which
provides $50,000 for salary, laboratory supplies, and limited domestic travel
for any area of cancer research. |
|
|
|
ACS-Barbara Thomason Research
Professorship or Clinical Research Professorship for Ovarian Cancer |
The award
is intended for an outstanding mid-career investigator who has made seminal
contributions to the understanding of the etiology, genetics, pathogenesis,
epidemiology, diagnosis or treatment of ovarian cancer and who continues to
provide leadership in this research area.
Applications from distinguished investigators in all categories of
ovarian cancer research, including basic, translational, clinical and applied
research, are requested. |
|
|
Applications
for funding to support a competitive program in brain and immuno-imaging |
This
program seeks to accelerate the development and application of innovative
cellular and molecular imaging to clinical research on the functions and
malfunctions of the brain, the immune system, and their interactions, in
normal and aberrant functioning. Successful applicants proposing to undertake
research using conventional brain tissue imaging technologies will receive
funding totaling up to $100,000 over a period of up to three years.
Applicants for a cellular or molecular imaging project can request up to
$300,000 for a period of up to three years. |
|
|
The award
is designed to support the original clinical breast cancer research of an
active ASCO member who holds a full-time faculty appointment at an academic
medical center. |
|
|
|
Avon Foundation - AACR Int’l
Scholar Awards in Breast Cancer Research |
The Avon
Foundation-AACR International Scholar Awards in Breast Cancer Research
provide Principal Investigators conducting breast cancer research in the |
|
|
Multiple
NIH institutes invite applications for Bioengineering Research Partnerships
to support basic, applied and translational multidisciplinary research that
addresses important biological or medical research problems. |
|
|
|
The
Brain Tumor Society invites applications for basic scientific research on
brain tumors directed at finding a cure. Any project with the potential to
advance basic scientific brain tumor research will be considered. Clinical projects will not be funded. |
|
|
|
This
program provides investigators with the opportunity to pursue serendipitous
observations and explore new, untested ideas relevant to breast cancer.
Approximately $10 million is expected to be available for 80 awards.
Applicants may request up to $75,000 in direct costs over a one-year project
period, plus indirect costs as appropriate. Cost-sharing of 50 percent for
major equipment purchased is anticipated. Eligibility is unrestricted. |
|
|
|
The
Cancer Education Grant Program employs the R25 grant mechanism to provide
funding for the development of innovative cancer education and research
dissemination projects. R25 education grants may focus on education for a
variety of target audiences: science or health care students with an interest
in cancer research careers; established cancer scientists seeking short term
educational updates in emerging cancer science areas such as genetics and
molecular drug discovery; and health care providers in need of information on
the latest developments in cancer prevention and control. |
|
|
|
Cancer
Intervention and Surveillance Modeling Network (CISNET) |
The
Division of Cancer Control and Population Sciences (DCCPS), National Cancer
Institute (NCI), invites applications from domestic and foreign applicants to
support collaborative research using simulation and other modeling techniques
to describe the Impact of interventions (i.e., primary prevention, screening,
and treatment) in population-based settings in the United States or in non-US
settings that will shed light on US population-based trends. |
|
|
The
Division of Cancer Prevention of the National Cancer Institute (NCI) invites
applications that address developmental research in chemoprevention agent
development, biomarkers, early detection, and nutrition science. |
|
|
|
Two-year
grants for junior faculty at the level of Instructor, Acting Assistant
Professor, and Assistant Professor, which provide $50,000/year for direct
research expenses. Areas of support
include gastrointestinal and pancreatic cancer research and research in
angiogenesis. |
|
|
|
CCOP
CANCER PREVENTION PILOT FUNDS (CALGB) |
CALGB
is pleased to announce the availability of funds to support pilot projects in
cancer prevention. These funds are available from our CCOP Research Base
grant supported by the NCI Division of Cancer Prevention. Any
investigator at a CALGB main member, at-large member, CCOP or affiliate is
eligible to apply. |
|
|
This
Request for Applications (RFA) solicits applications searching for new
cellular and genetic markers associated with the origin and progression of myeloproliferative disorders (MPD) that can be applied to
the future development of novel therapeutics with curative intent. A separate RFA HL-04-033 (please see http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-04-033.html)
is directed towards myelodysplastic syndromes. Applicants are directed to apply to one or
the other but not both RFAs. |
|
|
|
The Doris
Duke Clinical Interfaces Award Program seeks to catalyze activity at the
interface of clinical and other research disciplines by: 1) Supporting the
formation of new collaborations and strengthening existing collaborations of
outstanding scientists across disciplines; 2) Demonstrating successful models
for clinical research at the interface of multiple disciplines; and 3)
Supporting interdisciplinary and inter-institutional endeavors that go beyond
the program project mindset. |
|
|
|
DDCF
invites applications for the Doris Duke Clinical Scientist Development Award.
This award is made to junior physician-scientists to facilitate their
transition to independent clinical research careers. |
|
|
|
Collaborations with National Centers
for Biomedical Computing |
The
purpose of this program announcement is to provide support for investigators
working in collaboration with the NIH National Centers for Biomedical
Computing (NCBC) using the R01 mechanism. |
|
|
Comprehensive
Minority Institution/Cancer Center Partnership |
The
purpose of this grant is to provide opportunities for intensive
collaborations among MSIs and the |
|
|
Cooperative
Planning Grant for Comprehensive Minority Institution/ Cancer |
The
purpose of this cooperative planning grant is to provide opportunities for
potential partners to develop plans and initiatives that will enable them to
become competitive for a U54 cooperative agreement in order to develop
stronger national cancer programs |
|
|
This
funding opportunity is intended to support correlative studies by using tumor
specimens collected during multi-institutional clinical trials. The Cancer
Therapy Evaluation Program (CTEP), the Cancer Diagnosis Program (CDP), and
the Cancer Biomarkers Research Group (CBRG) from the NCI will cooperatively
sponsor this funding opportunity. |
|
|
|
Concept
Awards are intended to fund an initial concept or theory that could give rise
to a testable hypothesis within breast cancer research. The Congressionally Directed Medical
Research Programs (CDMRP) plans to solicit electronic submissions for short (one-page) Concept Award
proposals. These awards can be requested for $75,000 in direct costs over a
12-month performance period, plus indirect costs as appropriate. |
|
|
|
The FY05
Clinical Trial Award is open to all eligible applicants with clinical trials
relevant to prostate cancer treatment, diagnosis, detection, or prevention. |
|
|
|
Established
Investigator Award in Cancer Prevention and Control (K05) |
The award is
designed for established scientists who have already demonstrated a
sustained, high level of research and mentoring productivity and who need K05
support to continue these activities. The award provides partial salary
support for up to 5 years and for up to 50 percent effort. It is renewable
for one additional 5-year period." |
|
| Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (PA-05-165) | The objective of this Program Announcement is to encourage grant applications for exploratory (R21) grants from individuals who are interested in testing new ideas that may advance progress in cancer detection, diagnosis, and prognosis. | multiple dates |
|
The
CAREER program recognizes and supports the early career-development activities of those teacher-scholars who are most
likely to become the academic leaders of the 21st century. CAREER awardees
will be selected on the basis of creative career-development plans that effectively
integrate research and education within the context of the mission of their
organization. |
|
|
|
Freedom to Discover Award for Distinguished
Achievement in Cancer Research |
Bristol-Myers
Squibb Company will present an annual award to a scientist making an
outstanding contribution to progress in cancer research. Candidates for the
award are to be nominated by individuals affiliated with medical schools,
hospitals and cancer research centers. |
|
|
Funding to support research in the
development of HIV/AIDS drug therapeutics |
Research
areas include drugs aimed at treating infection, prophylactic vaccines and microbicides designed to prevent transmission of the
virus. Approximately $250,000 is available for awards, which will range from
$25,000 to $150,000. Applicants must have an M.D., Ph.D. or the equivalent
and work in academic centers, nonprofit institutions, or for-profit
businesses such as biotech start-up companies. |
|
|
Proposals
on the structure, maintenance, expression, transfer, and stability of genetic
information in DNA, RNA, and proteins and how those processes are regulated
are appropriate. Areas of interest include genome organization, molecular and
cellular evolution, replication, recombination, repair, and vertical and
lateral transmission of heritable information |
|
|
|
Proposals
on the structure, maintenance, expression, transfer, and stability of genetic
information in DNA, RNA, and proteins and how those processes are regulated
are appropriate. Areas of interest include genome organization, molecular and
cellular evolution, replication, recombination, repair, and vertical and
lateral transmission of heritable information |
|
|
|
This
grant supports research aimed at furthering the development of gene therapy
approaches to the treatment of cancer. One award of up to $1 million
distributed over 3-5 years is anticipated. Applicants must hold an M.D.,
Ph.D., or equivalent degree and be a tenure-track or tenured faculty. |
|
|
|
LI-COR
Biosciences invites applications for funding under the Genomics Education
Matching Fund program to help undergraduate colleges and high schools
establish or enhance programs in genomic studies. The program supports the
acquisition of LI-COR DNA sequencing instruments and software for use by
students studying molecular biology and related fields. Approximately $2
million is available for individual matching fund grants of up to $50,000.
Awards may be used toward the purchase of a LI-COR DNA Analysis System,
including instrument, software and reagents |
|
|
|
The
Cancer Imaging Program, Division of Cancer Diagnosis and Treatment of the National
Cancer Institute (NCI), invites applications for new or competing P50
Research Center Grants for In Vivo Cellular and |
|
|
|
The
Division of Digestive Diseases and Nutrition at the National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK) and the Division of Cancer Prevention
at the National Cancer Institute (NCI) invites applications through the
exploratory/developmental (R21) grant mechanism from investigators with
research interests in gastroenterology, hepatology,
obesity, and nutrition and that serve the mission of NIDDK and NCI. The aim of
this program announcement is to stimulate the application of highly novel approaches
to important areas of digestive diseases (including associated cancers) and nutrition research. |
|
|
|
This program supports the development
of novel or of substantially improved instrumentation likely to have a
significant impact on the study of biological systems at any level.
Approximately $2.5 million in FY 2005 funding is expected to be available for
15 awards. Eligible are |
|
|
|
Applications
will address the interdependent issues of biodiversity conservation, economic
capacity, and human health through discovery and development of therapeutic
agents for diseases of importance in developing countries, as well as those
important to developed countries. |
|
|
|
This
program supports highly qualified individuals to undertake broad studies of
the most challenging policy issues in health and health care facing |
|
|
|
J.P.
McCarthy Fund Developmental Grant |
The objective of the J.P. McCarthy Developmental Grant Program
is to strengthen the base of high-quality research in hematological diseases
in the major research universities and medical centers across the country.
Innovative hypothesis-driven developmental projects in basic, translational
and clinical research will be considered for funding. |
|
|
Joan's Legacy (lung
cancer) |
Joan''s Legacy invites grant applications for
institutional research that studies lung cancer. The foundation is
particularly interested in the genetic basis and biology of bronchoalveolar carcinoma as well as novel therapeutic
approaches for the treatment of this disease.
This funding is intended primarily as seed money for promising new work |
|
|
Joan's
Legacy invites grant applications for institutional research that studies
lung cancer. The foundation is particularly interested in the genetic basis
and biology of bronchoalveolar carcinoma as well as
novel therapeutic approaches for the treatment of this disease. This
funding is intended primarily as seed money for promising new work |
|
|
|
The
Kimmel Foundation is seeking accomplished young investigators dedicated to a
career in cancer research. Applications are limited to those who achieved the
equivalent rank of Assistant Professor on or after July, 2001. Physicians who
have both clinical and research responsibility are eligible if appointed on
or after July 2000. |
|
|
|
Leukemia & Lymphoma
Society (L&LS) Career Development Program |
The
L&LS Career Development Program provides awards intended to meet the specific needs of investigators at different
states in their research careers. The awards provide stipends to investigators,
allowing them to devote themselves to research bearing on leukemia, lymphoma
and myeloma. |
|
|
This
announcement is directed towards junior faculty with a strong commitment to an
investigative career in the field of ovarian cancer research. The intent of
these awards is to support a substantial time commitment to research and
academic endeavors in ovarian cancer. |
|
|
|
The goal
of this initiative is to make rapid advances in the battle against pancreatic
cancer through a combination of cutting edge technology and novel ideas. Applications will be accepted from
individual investigators as well as collaborating investigators. |
|
|
|
MIDCAREER
INVESTIGATOR AWARD IN PATIENT-ORIENTED RESEARCH (K24) |
The
purpose of the Midcareer Investigator Award in
Patient-Oriented Research is to provide support for clinician investigators
to allow them protected time to devote to patient-oriented research (POR) and to act as research
mentors primarily for clinical residents, clinical fellows and/or junior
clinical faculty. |
|
|
Molecular
Approaches to Diet and Pancreatic Cancer Prevention |
The
purpose of this initiative is to invite innovative preclinical and clinical
R01 applications to determine how dietary energy intake and bioactive food
components, including alcohol, influence pancreatic cancer development and
prevention. |
|
|
Molecular
screening assay development for sickle cell disease |
The goal
is to provide biological assays for automated, high throughput screening of
compounds that can potentially be used to improve the understanding of the
biology of SCD and provide inroads toward new agents for SCD treatments.
Approximately $300,000 in FY 2005 funding is expected to be available for
three awards having a project period of up to two years. |
|
|
Multidisciplinary
Clinical Research Career Development Programs |
These
programs support the early career development of clinical researchers
expected to achieve excellence in their ability to design and oversee
research in multidisciplinary team settings, and have a high potential to
become leaders of various fields of clinical research. Candidates who are |
|
|
Proposals
should address plans to identify and validate molecular targets for multiple myeloma. Short
proposals, in the form of abstracts, will be reviewed by an MMRF scientific
review panel. A group of applicants will be selected to attend and present at
a Research Roundtable with the MMRF and its external scientific advisors in
January 2005. Goals of
the Multiple Myeloma Therapeutic Targets
initiative: - Identify
molecular targets for multiple myeloma - Validate
targets for intervention for multiple myeloma - Prioritize
critical targets for multiple myeloma |
|
|
|
This
program supports partnerships between science educators and nanoscale science and engineering researchers and seeks
to increase knowledge of advances in nanoscale
research and technology. Approximately $7.5 million in FY 2005 funding is
expected to be available for 16 awards. |
|
|
|
NCI Transition
Career Development Award to Promote Diversity |
This award is intended to facilitate
the transition of underrepresented postdoctoral research scientists from the
mentored to the independent stages of their careers in cancer research. The
unique feature of this award is that the individuals may apply without a
sponsoring institution while they are still in a mentored position. |
|
|
The
purpose of this program announcement (PA) is to encourage the submission of
applications for research to enhance animal stem cells as model biological systems. |
|
|
|
OSU
Cancer Program Research Infrastructure Support and Enhancement (RISE)
Awards |
The
purpose of the RISE awards are to provide funding to investigators for
research infrastructure to support collaborative projects that will seek NCI
support through a programmatic grant to be submitted in the 2005-06 funding
cycle. It is anticipated that awards
may range from $50,000 to $125,000 for a one year period. |
|
|
OSUCCC/CPHHD
Pilot Project RFA ( |
The
purpose of these awards is to provide funding to investigators for pilot
projects as part of the |
|
|
OCRF
grants provide funding for the initial development of new basic and
translational ovarian cancer research projects. The purpose of this program is to provide
seed money that can be invested in studies with the potential to yield
preliminary data that can then be used to apply for other larger grants. Areas of emphasis include screening and
early detection, prevention, molecular therapeutics, cancer biology and
genetics. |
|
|
|
|
This award provides funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research. Trainees may be involved in either laboratory, clinical or epidemiology research. Those eligible to apply include: 1) Clinical fellows (Gynecologic Oncology, Medical Oncology, etc.) 2) Post-doctoral fellows |
|
|
Partnership
for Interdisciplinary Graduate Research Training initiative |
This
initiative aims to facilitate the development of new training opportunities
in emerging interdisciplinary research environments. |
|
|
The Paul
Marks Prize recognizes outstanding young investigators who have made
significant contributions to increase the understanding of cancer or improve
the treatment of the disease through basic or clinical research. |
|
|
|
The
Division of Kidney, Urologic and Hematologic
Diseases (DKUHD) of the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) and the Division of Cancer Biology of the National
Cancer Institute (NCI) of the National Institutes of Health (NIH) invite
exploratory/developmental (R21) grant applications from investigators with
research interests in urology and that serve the mission of NIH. |
|
|
|
The Division of Cancer Control and
Population Sciences (DCCPS), Division of Cancer Biology (DCB), Division of
Cancer Prevention (DCP), and Division of Cancer Treatment and Diagnosis
(DCTD) of the National Cancer Institute (NCI) invite Exploratory Grant (R21)
and Small Grant (R03) applications relating to the biology, etiology,
detection, prevention, and treatment of pancreatic cancer. These are
short-term awards intended to provide support for pilot projects, testing of
new techniques, and/or development of innovative projects that could provide
a basis for more extended research. |